Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Becton Dickinson & Co

09/03/2021 | 10:18am EDT


ę MT Newswires 2021
All news about BECTON, DICKINSON AND COMPANY
10/26BD to Host Investor Day on November 12
PR
10/26BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Tes..
PR
10/25BECTON DICKINSON AND : BD Names Dr. Carrie Byington To Board Of Directors
AQ
10/22BECTON DICKINSON & CO : Change in Directors or Principal Officers (form 8-K)
AQ
10/22Becton, Dickinson and Company Names Dr. Carrie Byington To Board Of Directors
CI
10/19BECTON DICKINSON AND : BD Launches New 'Together We Advance' Environmental, Social, Govern..
AQ
10/18Becton, Dickinson Unveils ESG Strategy for 2030
DJ
10/18BECTON DICKINSON AND : BD Launches New 'Together We Advance' Environmental, Social, Govern..
PR
10/13BECTON DICKINSON AND : BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enh..
PU
10/07BECTON DICKINSON AND : Expands Capacity at Manufacturing Facility in Nebraska
MT
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2021 20 009 M - -
Net income 2021 2 231 M - -
Net Debt 2021 14 944 M - -
P/E ratio 2021 32,0x
Yield 2021 1,50%
Capitalization 70 749 M 70 749 M -
EV / Sales 2021 4,28x
EV / Sales 2022 4,31x
Nbr of Employees 72 000
Free-Float 78,2%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 246,35 $
Average target price 270,20 $
Spread / Average Target 9,68%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Chris DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY-1.55%70 749
ABBOTT LABORATORIES17.02%227 151
MEDTRONIC PLC5.90%166 948
HOYA CORPORATION21.09%55 803
DEXCOM, INC.52.99%54 725
SARTORIUS STEDIM BIOTECH64.29%51 129